Search

Your search keyword '"Luca, Ceriani"' showing total 206 results

Search Constraints

Start Over You searched for: Author "Luca, Ceriani" Remove constraint Author: "Luca, Ceriani" Database OpenAIRE Remove constraint Database: OpenAIRE
206 results on '"Luca, Ceriani"'

Search Results

2. Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

3. Postoperative thyroglobulin as a yard-stick for radioiodine therapy : decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer

4. Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma

5. Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules

6. Planning with Always Preferences by Compilation into STRIPS with Action Costs

7. Optimal timing and criteria of interim PET in DLBCL: A comparative study of 1692 patients

8. The Role of 2-[18F]-FDG PET/CT in Detecting Richter Transformation in Chronic Lymphocytic Leukemia: A Systematic Review

9. D

10. Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib

11. Author response for 'Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib'

12. International Impact of COVID-19 on the Diagnosis of Heart Disease

13. Radiomics Analysis of [18F]-Fluorodeoxyglucose-Avid Thyroid Incidentalomas Improves Risk Stratification and Selection for Clinical Assessment

14. Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma

15. SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

16. Sciatic pain by neurolymphomatosis as initial presentation of disseminated diffuse large B cell lymphoma involving the testis and the CNS

17. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis

18. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

20. The role of thyroglobulin doubling time in differentiated thyroid cancer : A meta-analysis

21. SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

22. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

24. Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study

25. CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?

27. An Evanishing Thyroid During Immune Checkpoint Inhibitor Therapy

28. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis

29. Author response for 'Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis'

30. Role of18F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients

31. Fine-needle aspiration to diagnose primary thyroid lymphomas: a systematic review and meta-analysis

32. Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume

33. Tc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities

34. Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

35. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma

36. DEVELOPMENT AND VALIDATION OF A PET RADIOMICS PROGNOSTIC MODEL FOR DIFFUSE LARGE B CELL LYMPHOMA

37. GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMA

38. CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA

39. INTEGRATION OF BASELINE METABOLIC PARAMETERS AND MUTATIONAL PROFILE PREDICTS OUTCOME IN DLBCL PATIENTS. A POST HOC ANALYSIS OF SAKK38/07 STUDY

40. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

41. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma

42. Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma

43. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

44. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

45. Clinical performance of calcitonin and procalcitonin Elecsys

46. Author response for 'Prognostic Models Integrating Quantitative Parameters from Baseline and Interim Positron Emission Computed Tomography in Patients with Diffuse Large B‐Cell Lymphoma: Post‐Hoc Analysis from the SAKK38/07 Clinical Trial'

47. Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial

48. Radiomics Analysis of [

49. Diagnostic Performance of 18F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis

50. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis

Catalog

Books, media, physical & digital resources